| SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors AS Shomuradova, MS Vagida, SA Sheetikov, KV Zornikova, D Kiryukhin, ... Immunity 53 (6), 1245-1257. e5, 2020 | 259 | 2020 |
| Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection AA Minervina, EA Komech, A Titov, M Bensouda Koraichi, E Rosati, ... Elife 10, e63502, 2021 | 136 | 2021 |
| VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2 M Goncharov, D Bagaev, D Shcherbinin, I Zvyagin, D Bolotin, PG Thomas, ... Nature methods 19 (9), 1017-1019, 2022 | 128 | 2022 |
| Cell-type–restricted anti-cytokine therapy: TNF inhibition from one pathogenic source GA Efimov, AA Kruglov, ZV Khlopchatnikova, FN Rozov, VV Mokhonov, ... Proceedings of the National Academy of Sciences 113 (11), 3006-3011, 2016 | 94 | 2016 |
| Tumor necrosis factor, lymphotoxin and cancer MS Drutskaya, GA Efimov, AA Kruglov, DV Kuprash, SA Nedospasov IUBMB life 62 (4), 283-289, 2010 | 75 | 2010 |
| Pattern of circulating SARS‐CoV‐2‐specific antibody‐secreting and memory B‐cell generation in patients with acute COVID‐19 M Byazrova, G Yusubalieva, A Spiridonova, G Efimov, D Mazurov, ... Clinical & Translational Immunology 10 (2), e1245, 2021 | 62 | 2021 |
| Tumor Necrosis Factor and the consequences of its ablation in vivo GA Efimov, AA Kruglov, SV Tillib, DV Kuprash, SA Nedospasov Molecular immunology 47 (1), 19-27, 2009 | 44 | 2009 |
| Modern anti-cytokine therapy of autoimmune diseases IV Astrakhantseva, GA Efimov, MS Drutskaya, AA Kruglov, ... Biochemistry (Moscow) 79, 1308-1321, 2014 | 40 | 2014 |
| VHH-based bispecific antibodies targeting cytokine production MA Nosenko, KSN Atretkhany, VV Mokhonov, GA Efimov, AA Kruglov, ... Frontiers in immunology 8, 1073, 2017 | 38 | 2017 |
| Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors D Wu, A Kolesnikov, R Yin, JD Guest, R Gowthaman, A Shmelev, ... Nature Communications 13 (1), 19, 2022 | 37 | 2022 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific T cells and antibodies in coronavirus disease 2019 (COVID-19) protection: a prospective study IA Molodtsov, E Kegeles, AN Mitin, O Mityaeva, OE Musatova, AE Panova, ... Clinical Infectious Diseases 75 (1), e1-e9, 2022 | 34* | 2022 |
| Single-domain antibody-based ligands for immunoaffinity separation of recombinant human lactoferrin from the goat lactoferrin of transgenic goat milk SV Tillib, ME Privezentseva, TI Ivanova, LF Vasilev, GA Efimov, ... Journal of Chromatography B 949, 48-57, 2014 | 34 | 2014 |
| Methods for in vivo molecular imaging AA Kuchmiy, GA Efimov, SA Nedospasov Biochemistry (Moscow) 77, 1339-1353, 2012 | 34 | 2012 |
| Public T-cell receptors (TCRs) revisited by analysis of the magnitude of identical and highly-similar TCRs in virus-specific T-cell repertoires of healthy individuals W Huisman, L Hageman, DAT Leboux, A Khmelevskaya, GA Efimov, ... Frontiers in immunology 13, 851868, 2022 | 26 | 2022 |
| Can we design a better anti-cytokine therapy? MS Drutskaya, GA Efimov, AA Kruglov, SA Nedospasov Journal of Leukocyte Biology 102 (3), 783-790, 2017 | 26 | 2017 |
| Interleukin-6: From molecular mechanisms of signal transduction to physiological properties and therapeutic targeting MS Drutskaya, MA Nosenko, KSN Atretkhany, GA Efimov, ... Molecular Biology 49, 837-842, 2015 | 26 | 2015 |
| Experimental models of arthritis in which pathogenesis is dependent on TNF expression MS Drutskaya, GA Efimov, RV Zvartsev, AA Chashchina, DM Chudakov, ... Biochemistry (Moscow) 79, 1349-1357, 2014 | 26 | 2014 |
| In Silico Analysis of the Minor Histocompatibility Antigen Landscape Based on the 1000 Genomes Project NA Bykova, DB Malko, GA Efimov Frontiers in Immunology 9, 1819, 2018 | 25 | 2018 |
| Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation MG Byazrova, SV Kulemzin, EA Astakhova, TN Belovezhets, GA Efimov, ... Frontiers in Immunology 13, 840707, 2022 | 24 | 2022 |
| Cancer immunotherapy based on the blockade of immune checkpoints AV Bogolyubova, GA Efimov, MS Drutskaya, SA Nedospasov Medical Immunology (Russia) 17 (5), 395-406, 2015 | 23 | 2015 |
Dmitry MalkoThe Weizmann Institute of Scienceweizmann.ac.il의 이메일 확인됨